32results about How to "Good treatment compliance" patented technology

The disclosure is directed to a process and system for managing the end-to-end process of obtaining research data from patients and/or participants in a Clinical Trial. The process enables collection of appropriate informed consent from patient/participants via electronic devices such as smart phones and tablets. Additionally, the system uses biometric information such as finger prints, face pictures, digital signature to provide additional information concerning a participant. This helps to make the whole informed consent process effortless, paperless and transparent. An aspect of the disclosure enables investigators to reach out to a wider patient/participant population irrespective of their physical location. Thus the platform enables investigators to collect and transfer real time data, seamlessly from across the world.

Apparatuses, systems and methods for the wireless communication of medical devices in a subcutaneous fluid delivery system are disclosed. A system for subcutaneous fluid delivery includes a primary patch pump adapted to attach a first infusion cannula to a user and to perform a plurality of primary patch pump functions, and a secondary patch pump adapted to attach a second infusion cannula to a user. The secondary patch pump is further adapted to perform a plurality of secondary patch pump functions substantially similar to the plurality of primary patch pump functions if an error condition associated with the primary patch pump is determined.

The invention provides a Chinese patent medicine preparation for treating chronic obstructive pulmonary disease, which comprises traditional Chinese medicine raw ingredients by weight proportions as follows: radix astragali is 30 to 50, ginseng 6 to 12, Salvia miltiorrhiza is 15 to 30, old arable soil is 20 to 50, ophiopogon roots are 10 20, and tuber pinellia is 6 to 10. The Chinese patent medicine preparation is prepared by the following method: the traditional Chinese medicine raw ingredients are obtained, crushed together, and processed into fine powders over 100 screen meshes according to the prescription, the fine powders are mixed uniformly and sterilized by ozone for 20 minutes to make dosage form of capsules, or the fine powders are added with honey and mixed uniformly to make the dosage form of pills. The Chinese patent medicine preparation is a pure TCM preparation, the traditional Chinese medicine raw ingredients are combined, and the purposes of replenishing spleen as well as lung and heart as well as kidney, eliminating phlegm stasis, and treating both cause and symptom are achieved; the Chinese patent medicine preparation has remarkable curative effect for treating the chronic obstructive pulmonary disease, simple production method, low cost, no obvious toxic and side effects, and easy acceptance by patients.

The invention provides a composition comprising an effective dose of etimicin or a pharmaceutically acceptable salt thereof, an anti-inflammatorily effective dose of steroids or non-steroid anti-inflammatory drugs, and an effective dose of a water-retaining or wetting agent or anti-xerophthalmia drug, and application of the composition to preparation of external drugs for local administration of the eyes, the nose or skin and for prevention and treatment of conjunctivitis in human beings or mammals, angular blepharitis, keratitis, scleritis, trachoma, xerophthalmia, cataract, otitis externa, otitis media, folliculitis, furuncle, pustule and the like. The composition provided by the invention has better curative effect or treatment compliance.

The invention discloses a method for preventing mechanical phlebitis caused by PICC (peripherally inserted central catheter) catheterization. According to the method, an electric knee pad is used as an elbow guard which dry-heats to prevent the mechanical phlebitis caused by PICC catheterization. The method includes the steps: the electric knee pad is tied to an upper arm of a puncture side limb 12 hours after a successful PICC catheterization, the range of skin temperature is kept between 37 DEG C and 41 DEG C by adjusting the temperature of the electric knee pad, and each single temperature holding is performed for 30-40 minutes three times a day and is continued for 3-4 days. The method has the advantages that constant temperature and uniform time are adopted, a puncture spot is avoided, a primary site of mechanical phlebitis at the position 5cm above the puncture site is included, occurrence rate of mechanical phlebitis is significantly reduced, and prevention effect is significant; the method is simple and easy, temperature and time execution differences during therapy are small, influencing factors are few, working strength is never excessively increased for medical staff, good comfortableness and treatment compliance are achieved for patients, and paint and economic burden are reduced for patients.

The invention relates to a traditional Chinese medicine composition for treating tumors. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15 to 17 parts of rhizoma polygonati, 22 to 23 parts of radix polygoni multiflori preparata, 24 to 26 parts of mulberry fruit, 3 to 7 parts of periostracum cicadae, 2 to 8 parts of liquidambar orientalis, 2 to 8 parts of benzoin, 2 to 5 parts of bombyx batryticatus, 7 to 10 parts of herba pimpinellae, 20 to 25 parts of rhizoma corydalis, 25 to 35 parts of poria cocos, 5 to 15 parts of radix trichosanthis, 1 to 10 parts of fructus cnidii, and 10 to 15 parts of liquorice root. The traditional Chinese medicine composition for treating the tumors has the advantages that the convenience in use is realized, the curative effect is obvious, the traditional Chinese medicine composition is suitable for clinical popularizing, and the good commercial prospect is realized.

The invention discloses an idiopathic thrombocytopenic purpura medicament composition. The medicament composition is prepared by active pharmaceutical ingredients including, by weight, 100-200 parts of Gynura segetum, 50-150 parts of forsythia, 100-200 parts of field thistle, 100-200 parts of rehmannia, 10-100 parts of fried gardenia, 50-100 parts of savatier monochasma and 50-150 parts of fried yams. A preparation method of the idiopathic thrombocytopenic purpura medicament composition includes steps of weighting the active pharmaceutical ingredients according to the formulas, evenly mixing the active pharmaceutical ingredients by grinding, extracting water and concentrating or the combination of the both, and then obtaining the medicament composition. The medicament composition is capable of cooling blood and stopping blood, clearing heat and removing toxicity, and is used for various hemorrhages caused by the heat forced blood line and the blood overflowing outside pulse such as bleeding gums, blood oozing out of nasals, skin purpura, hemafecia, hematuria and menorrhagia .

The invention provides preparation of an effective dose of puerarin or pharmaceutically acceptable salts thereof and the like and an effective dose of brimonidine or pharmaceutically acceptable salts thereof or/and an effective dose of anti-xerophthalmia pharmaceutical composition. The invention also relates to an application of the compound in preparation of ophthalmic medicines for preventing or treating intraocular pressure of human or mammals or treating intraocular pressure rise, glaucoma, fundus diseases, xerophthalmia or dry eye diseases or dry eye syndromes, and local medicines for acne rosacea, erythema rosacea and the like. The medicine provided by the invention has better curative effect or lower side effect or better treatment compliance or better treatment mode.

The invention relates to a traditional Chinese medicine composition for treating mammary gland fibroma and mammary gland hyperplasia. The traditional Chinese medicine composition is prepared from the following raw materials: caulis spatholobi, pig trotter shells, herba violae, centipedes, scorpions, angelica sinensis, lonicera japonica, trichosanthes kirilowii maxim, spina gleditsiae and flos chrysanthemi indici. According to the composition, the medicine components of the composition are screened through reasonable monarch, minister, assistant and guide, the caulis spatholobi, the pig trotter shells and herba violae are taken as monarch drugs, the centipedes, the scorpions, the angelica sinensis and the lonicera japonica are taken as ministerial drugs, the trichosanthes kirilowii maxim and the spina gleditsiae are taken as adjuvant drugs, the flos chrysanthemi indici are taken as guide drugs, and yellow wine is taken as a guide drug for taking the medicine. The traditional Chinese medicine composition mainly exerts the coordinated drug properties of the caulis spatholobi, the pig trotter shells and the herba violae for soothing liver and regulating qi, promoting blood circulation to remove blood stasis, regulating endocrine and softening hardness to dissipate stagnation, then combines the functions of the centipedes, the scorpions, the angelica sinensis and the lonicera japonica for detoxifying and dispelling cold, activating meridians to stop pain with abdominal mass and aggregation, and is used in a specific proportion, so that the drug efficacy directly reaches the focus, the immune function of a patient is improved, and the endocrine hormone level of a patient is regulated, thereby effectively treating the mammary gland fibroma and the mammary gland hyperplasia and especially the condition that the two diseases occur simultaneously.

The invention discloses application of ceramide in preparation of a kit for evaluating the risk of occurrence of adverse events of hypertension high-risk patients. The invention further discloses a kit for evaluating or assisting in evaluating the risk of cardiovascular adverse events of the high-risk hypertension patient. The kit comprises a product for detecting the content of ceramide in a biological sample of the high-risk hypertension patient. The kit further comprises a carrier recording the following judgment standards: for a hypertension high-risk patient, performing quartile on the plasma ceramide ratio, and judging that the patient has the rising risk of a cardiovascular event when the plasma ceramide ratio is at a higher third quantile; and when the plasma ceramide ratio is at a higher quartile, judging that the patient has the rising risk of the cardiovascular event; when the ceramide score -1 is greater than or equal to 7, or the CERT-HBP is greater than or equal to 3, judging that the patient has the rising risk of the cardiovascular event.

The invention provides a medicine composition containing an effective dosage of puerarin and an effective dosage of dorzolamide or brinzolamide or prostaglandin, such as latanoprost, tafluprost and the like or/ and an effective dosage of water-retaining agent or wetting agent or antixerophthalmic ingredients, and application in preparation of medicines, including eye-purpose medicines used for preventing or treating intraocular pressure or elevated intraocular pressure, glaucoma, fundi diseases, optic nerve protection, dry eyes or xerophthalmia or dry eye syndromes of the human being or mammals. The medicine disclosed by the invention has a better curative effect or a smaller side effect or better treatment compliance or a better treatment mode.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for easing pain. The traditional Chinese medicine compositionis prepared from rhizoma corydalis, caulis polygoni multiflori, rhizoma Chuanxiong, radix angelicae sinensis, ramulus uncariae cum uncis, radix angelicae pubescentis, notopterygium roots, myrrh, radix astragali, the roots of bidentate achyranthes, radix saposhnikoviae, licorice roots, semen ricini, radix clematidis, mulberry twigs, radix moridae officinalls, cassia bark, cassia twigs, herba lycopi, plant oil and red lead. The invention further provides a preparation method of the traditional Chinese medicine composition for easing pain. The traditional Chinese medicine composition for easingpain can significantly ease the pain induced or worsened by emotional factors, the treatment effect is definite, and the effect is significant.

The embodiment of the invention provides an external counterpulsation pressurization system. The external counterpulsation pressurization system comprises a control panel, a computer control center, an air source pressure controller, an air source device, a counterpulsation sequential electromagnetic valve, an air bag device and a sensor module. The control panel comprises a display module and a control module, the display module receives the air bag pressure information sent by the sensor module, and the control module sends a pressurizing requirement set by a user to the computer control center. The computer control center is connected with the air source pressure controller and the counterpulsation sequential solenoid valve, on one hand, air conveyed to an air bag by the air source device is controlled, and on the other hand, the inflation or deflation state of the air bag is controlled through the counterpulsation sequential solenoid valve, so that the pressure value of the air bagis increased to the gradient pressure value at most; and the gradient pressure value is gradually increased every preset time according to a preset rule and stops increasing after reaching a preset final pressure value, and the maximum pressure of the air bag in each counterpulsation period is kept at the final pressure value in the remaining treatment time. The sensor module collects the pressure value of the air bag device and transmits the pressure value to the control panel. According to the system, the pressure of the air bag can be slowly and gradually increased to the set treatment pressure in a multi-step mode according to different physical conditions and tolerance differences of patients, a gradually adapting process is provided for the patients, and the experience and treatmentcompliance of the patients are optimized.

The invention relates to an application of winter jasmine in preparing medicines for treating acute spinal cord injury (SCI), and particularly relates to a novel application of winter jasmine in the pharmaceutical field. In the treatment of acute SCI, winter jasmine has the advantages of definite and effective curative effect, low toxic and adverse effects and high safety. In the treatment of SCI, winter jasmine can up-regulate the expression of BDNF (Brain-derived neurotrophic factor) while down-regulating the expression of NMDA (N-methyl-D-aspartate) receptor, and can effectively improve the movement function of SCI rats.